Skip to main content

MSLE · Satellos Bioscience Inc. · Short Interest

Track MSLE — free
$6.88 +0.34 (+5.20%) At close · Oct 27 Q2 2026 earnings call transcript
Market Cap
$138.76M
Shares
21.22M
Volume · Oct 27 22.18K Avg daily vol (3M) 40.9K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

MSLE Latest Reported Short Interest

FINRA reported 97,288 MSLE shares sold short as of the October 15, 2026 settlement date, a decrease of 8,399 shares. Days to cover was 1.59 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

MSLE Short Interest Forecast

Equibles' model estimates 98,590 shares sold short for the October 30, 2026 settlement, +1.3% versus the latest reported position, with a likely range of 69,484 to 133,250 shares. This model prediction uses FINRA data through October 19, 2026; FINRA's official release is expected November 10, 2026.

Model estimate

Expected Oct 30 short interest

as of Oct 19 Low confidence 47% chance it rises
98,590 +1.3% vs reported
Likely range 69,484 to 133,250 The latest estimate appears in the chart below. Official release expected Nov 10. Methodology
Short Squeeze Score
30/100
Short interest 0.5% of shares — P32 Days to cover 1.6 — P32 Price vs VWAP -19.4% — P21 Short-volume trend -7.7% — P23 Short interest change -7.9% — P26 Worst FTD 0.01% of shares — P50

Positioning score 30.2 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-10-15). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

No active listed options were found.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-28 01:16 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-11-13 Scheduled
FINRA publishes Nov 24
— — — —
2026-10-30 Scheduled
FINRA publishes Nov 10
— — — —
2026-10-15 97,288 105,687 -8,399 1.59
2026-09-30 105,687 82,427 +23,260 1.58
2026-09-15 82,427 89,063 -6,636 2.58
2026-08-31 89,063 91,665 -2,602 4.28
2026-08-14 91,665 113,110 -21,445 3.38
2026-07-31 113,110 104,097 +9,013 1.69
2026-07-15 104,097 83,488 +20,609 1.00
2026-06-30 83,488 70,188 +13,300 1.74
2026-06-15 70,188 76,818 -6,630 1.92
2026-05-29 76,818 84,855 -8,037 3.00
2026-05-15 84,855 95,757 -10,902 2.54
2026-04-30 95,757 78,896 +16,861 1.93
2026-04-15 78,896 69,466 +9,430 1.10
2026-03-31 69,466 68,221 +1,245 1.00
2026-03-13 68,221 13,184 +55,037 1.00
2026-02-27 13,184 6,682 +6,502 1.00
2026-02-13 6,682 6,433 +249 1.00

Full FINRA short interest reporting calendar

Showing 1–17 of 17 settlements
Key facts CIK 1421642 CUSIP 80401L803 Visit website Investor relations